Screening compound: PPVOKEUQPPJUFV-UHFFFAOYSA-N

Screening compound: PPVOKEUQPPJUFV-UHFFFAOYSA-N
Screening compound: PPVOKEUQPPJUFV-UHFFFAOYSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
PPVOKEUQPPJUFV-UHFFFAOYSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

M334-0016

Molecular Formula

C24H24N6O4S (C24 H24 N6 O4 S)

Compound Name

N-(6-ethoxy-1,3-benzothiazol-2-yl)-2-[6-(5-methyl-1,2,4-oxadiazol-3-yl)-2-oxo-3-(propan-2-yl)-2,3-dihydro-1H-1,3-benzodiazol-1-yl]acetamide

IUPAC name

N-(6-ethoxy-13-benzothiazol-2-yl)-2-[6-(5-methyl-124-oxadiazol-3-yl)-2-oxo-3-(propan-2-yl)-23-dihydro-1H-13-benzodiazol-1-yl]acetamide

SMILES

CCOc(cc1)cc2c1nc(NC(CN(c(cc(cc1)-c3noc(C)n3)c1N1C(C)C)C1=O)=O)s2

InChI

InChI=1S/C24H24N6O4S/c1-5-33-16-7-8-17-20(11-16)35-23(26-17)27-21(31)12-29-19-10-15(22-25-14(4)34-28-22)6-9-18(19)30(13(2)3)24(29)32/h6-11,13H,5,12H2,1-4H3,(H,26,27,31)

InChI Key

PPVOKEUQPPJUFV-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27536855

PPVOKEUQPPJUFV-UHFFFAOYSA-N in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Allosteric Kinases Inhibitors Library (23117 compounds)

Anticancer Library (62698 compounds)

GPCR Targeted Library (31838 compounds)

Hsp90-Targeted Library (11355 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Akt-Targeted Library (14764 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases
  • GPCR
  • Others
  • Kinases
  • Kinases
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • Epigenetic
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with PPVOKEUQPPJUFV-UHFFFAOYSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound PPVOKEUQPPJUFV-UHFFFAOYSA-N?
Check Price and Availability of PPVOKEUQPPJUFV-UHFFFAOYSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of PPVOKEUQPPJUFV-UHFFFAOYSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for PPVOKEUQPPJUFV-UHFFFAOYSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for PPVOKEUQPPJUFV-UHFFFAOYSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of PPVOKEUQPPJUFV-UHFFFAOYSA-N available by request